Cardiopulmonary bypass (CPB) was used during the replacement of the aortic
and mitral valves in a 43year-old female patient. The case was complicated
by the presence of a rare hypercoagulable condition called anticardiolipin
(antiphospholipid) antibody syndrome. The course of bypass was uneventful a
nd the patient was released from the intensive care unit on the first posto
perative day. CPB in the presence of anticardiolipin antibodies is an unusu
al situation that requires diligent hematological monitoring. Since 1989 th
ere have been only 14 reported cases of these antibodies and cardiopulmonar
y bypass. Eight of these have involved valve replacements.